Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A new phase 2, open-label, randomized controlled trial published in Nature Medicine indicates that favipiravir is a safe, well-tolerated treatment alternative for mild-to-moderate Lassa fever. Conducted in Nigeria, the study ... Read More
Continuous Coverage
It’s 9:00 p.m. On a Thursday in May, and the air in Knoxville is thick with the kind…
An anonymous Reddit user just stumbled upon a YouTube channel generating boardgame videos entirely via AI—no human hands…
A Texas children’s hospital has been mandated to establish specialized clinical services for patients seeking to detransition, following…
The Oklahoma City Philharmonic’s “Music from the Movies!” outdoor concert drops this Sunday, May 17, at deadCenter Film…
The 2026 PGA Championship’s Round 3 on Saturday (May 17) will hinge on the resurgent form of Scottie…
Greenland sharks, living over 400 years, navigate deep oceans blind, relying on parasites—a biological anomaly mirroring tech’s reliance…
Global Affairs
Earlier this week in Modena, Italy, a vehicle was driven intentionally into a crowd of pedestrians, resulting in…
Markets And Money
As of May 16, 2026, the Egyptian gold market is experiencing a notable recalibration, with the gold coin…
Digital Culture
Google is fundamentally restructuring the Android Auto architecture to move beyond simple screen mirroring, introducing a widget-based interface…
Science And Wellbeing
Recent laboratory confirmation of hantavirus in a Canadian patient, followed by localized isolation protocols in British Columbia and…
Screen And Sound
Bulgarian pop sensation DARA has officially secured victory at the 2026 Eurovision Song Contest, held late this Saturday…
Fixtures And Form
Australian sprinter Andrew Caldwell (23) etched his name into the record books as the second-fastest Australian male ever…
